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The mouse Lyt-1, Lyt-2, and Lyt-3 lymphocyte surface antigens have been used for 
some years now as immunogenetic  markers  whose selective expression  distinguishes 
maturational  and  functional  T  cell  subpopulations  (1,  2).  Lyt-2  and  Lyt-3,  for 
example,  are  selectively  expressed  on  cytotoxic and  suppressor  T  cells  but  are  not 
found  on  helper  T  cells  (3,  4).  Similarly,  cytotoxic  depletion  studies  originally 
indicated that Lyt-1 is selectively expressed on helper T  cells but not on suppressor or 
cytotoxic T  cells (5, 6). More sensitive immunofluorescence techniques, however, have 
not shown that  Lyt-1 is found on all T  cells  (7-10)  but  is present  in higher levels on 
helper T  cells  than  on suppressor  or cytotoxic T  cells  (10).  In addition,  each of the 
Lyt-1, Lyt-2, and  Lyt-3 antigens undergoes characteristic  changes in surface-density 
expression as T  cells mature in the thymus and peripheral  lymphoid tissues  (9,  I0). 
Functional  subpopulations  of human  T  cells  have  also  been  defined  by selective 
expression of certain surface antigens.  Two subpopulations of T  cells were originally 
defined  by a  heteroantiserum  termed aTH2  (11). TH2  ÷ cells were shown to mediate 
suppressor effects in vitro and to be responsible for most of the killing in cell-mediated 
lympholysis (CML) 1 (12). In contrast, TH2- cells had markedly less cytotoxic activity 
in CML but were found to amplify the functions of other cells and to proliferate  in 
response to specific antigens  (mumps and tetanus toxoid)  (12). 
Recently, both of these subsets have been redefined by monoclonal antibodies  (13- 
15) 2 and analogies drawn between the human antigens and mouse Lyt antigens  (15). 
The analogy is  based  primarily  on the  view that  Lyt-1  is  expressed  on the  helper/ 
inducer but not the suppressor/cytotoxic subset in the mouse. As this view needs to be 
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revised  (see above), the human-mouse analogy also needs careful reevaluation  based 
on comparative quantitative  flow immunofluorescence, biochemical, developmental, 
as well as functional analyses. 
In this article, we show that the exclusive marker of the human helper/inducer  T 
cell  subset  has  no known  mouse counterpart,  whereas  the  human  T  cell  antigens, 
Leu-1, Leu-2a, and Leu-2b, have strong analogies to the mouse Lyt-1, Lyt-2, and Lyt- 
3  antigens,  respectively.  Our studies  indicate  that  molecules  carrying these  human 
Leu antigens approximate the size, charge, and subunit composition of the correspond- 
ing molecules carrying the mouse Lyt antigens.  Moreover, each of these structurally 
homologous  antigen  systems  has  similar  sensitivity  to  trypsin  and  shows  similar 
quantitative changes during T  cell maturation  in the thymus. 
The  molecules  carrying the  Leu  and  Lyt  antigens  have  undergone  evolutionary 
change  because  no  cross-reactivity  was  observed  between  murine  and  human  T 
lymphocyte  antigens  when  staining  with  either  anti-Lyt  or  anti-Leu  antibodies. 
Nevertheless, these molecules appear to have conserved their basic properties such as 
surface expression  patterns  and  molecular configuration.  This  finding suggests  that 
such properties may play a sufficiently valuable role to have favored retention through 
evolution. 
Materials  and Methods 
Source of Lymphoid Cells.  Mouse thymus or lymph node cells  were  from 8-  to  10-wk-old 
BALB/cNHz females.  Human  peripheral  blood cells  were  from  volunteers  in  the Medical 
Center at Stanford University, Stanford, Calif. Human thymuses were from children undergo- 
ing cardiac surgery and were kindly provided by Dr. R. Rouse, Stanford University. 
Monoclonal Antibodies.  Production of the mouse  (BALB/c) anti-human T  cell  monoclonal 
antibodies was previously described. 2 Production of the rat  (Lou/Wsl/M)  anti-mouse T  cell 
monoclonal antibodies also was previously described (8). 
Immunofluorescence of Cell Suspensions.  Immunofluorescence staining of mouse lymphoid cells 
with rat monoclonal antibodies was performed using directly fluorescein-conjugated antibodies. 
For the direct conjugations with fluorescein, antibodies were first  purified from supernate on 
goat anti-rat Ig affinity columns. (The goat anti-rat  Ig serum was kindly provided by Dr. R. 
Wilsnack, Huntingdon Research Center, Brooklandville, Maryland.) Fluorescein conjugations 
were with fluorescein isothiocyanate according to the method of Goding (16). Immunofluores- 
cence staining of human lymphoid cells with monoclonal mouse antibodies was performed with 
an  indirect  system  using  monoclonal  antibody-containing  supernate  in  the  first  step  and 
fluorescein-conjugated goat anti-mouse IgGi or fluorescein-conjugated goat anti-mouse IgG2 in 
the second step. For staining mouse or human cells, reagents were first centrifuged at  100,000 
g before use, and I06 target lymphoid cells/well in microtiter plates were reacted with saturation 
levels of first and second step reagents. Ceils were stained on ice in the presence of 0.01% NaN3 
as previously described (17). 
Cell Surface Labeling and Detergent Extraction.  BALB/cNHz thymocytes or lymph node cells 
were labeled with 125I by a modification of the lactoperoxidase technique. To 1 ×  108 cells in 
1 ml phosphate-buffered saline at 20°C were added  1.0 mCi ~5I (Amersham Corp., Arlington 
Heights, Ill.),  25 p,g lactoperoxidase (B grade; Calbiochemi-Behring Corp., American Hoeehst 
Corp., San Diego, Calif.)  and successive  10 #1 pulses  of H202 (0.3 mM,  1 mM, 3 mM, and 9 
mM) at 5-min intervals.  Cells were washed twice and extracted in lysis buffer (0.5% Nonidet P- 
40 [NP-40; Particle Data,  Inc., Elmhurst,  Ill.l;  50 mM Tris,  150 mM NaCI; 0.02%  NAN3, 5 
mM  EDTA;  50  mM  phenylmethylsulfonyl  fluoride;  0.2  TIU  [tryspin-inhibitor  unit]/ml 
Aprotjnin, [Sigma Chemical Co., St Louis, Mo.];  1/lg/ml pepstatin A, [Sigma Chemical Co.]; 
and 50 mM iodoacetamide, pH 8.0) for 30 rain at 4°C. Nuclei were removed by centrifugation 
at 5,000 g for 20 min. Human thymocytes or peripheral blood lymphocytes (isolated on Ficoll- 
Paque) were similarly labeled with x25I and lactoperoxidase in balanced salt solution. 312  HOMOLOGOUS MOUSE  AND  HUMAN T  CELL ANTIGENS 
Immunoprecipitation and Gel Electrophoresis.  Immunoprecipitations were with ~5/~g antibody/ 
extract  from 2  ×  107 cells.  After a  1-h incubation on ice,  antigen-antibody complexes were 
collected by the addition of 10 #1 of 10% formalin-fixed, heat-inactivated Staphylococcus aureus, 
Cowan I  strain  (staph  A; Tufts New  England Enzyme Center,  Boston,  Mass.).  For the rat 
antibodies  that  do not bind  to protein A directly,  the staph A  was precoated with affinity- 
purified mouse (SJL/J) anti-rat Ig and washed twice before addition to the cell extract. For the 
mouse yl antibodies that  do not bind to protein A directly, the staph A was precoated with 
affinity-purified rabbit anti-mouse Ig and washed twice before addition to the cell extract. After 
45  min on ice, the staph A-antibody-antigen complexes were washed three times in washing 
buffer (0.5% NP-40, 0.45 M NaCI, 50 mM Tris, 5 mM KI, and 0.02% NAN3; pH 8.3) and then 
extracted with sample buffer for gel electrophoresis. Immunopreeipitates were analyzed by 10% 
sodium  dodecyl sulfate  (SDS)-polyacrylamide one-dimensional  gels  (18).  Molecular  weight 
markers (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) run on each 
gel were visualized by staining with Coomassie brilliant blue (Bio-Rad Laboratories, Richmond, 
Calif.).  Radioautography was with intensifying screens  (Cronex lightning plus screens;  E. I. Du 
Pont  de Nemours & Co., Wilmington, Del.)  using Kodak X-Omat  R  film (Eastman  Kodak 
Co., Rochester, N. Y.) at -70°C. 
Results 
Lyt-2, Lyt-3 and Leu-2a,  Leu-2b Show Similar Biochemical Characteristics and Determinant 
Density Distributions  (Fluorescence-activated Cell Sorter [FACS]Profiles).  The Leu-2a and 
Leu-2b antigens in man, like the Lyt-2 and Lyt-3 antigens in mice (10), are lost from 
the  majority of thymocyte cells  as they mature.  Thus  they are  found on 80-90%  of 
thymocytes and 20-40% of peripheral T  cells (Fig.  1). The distinction between positive 
and  negative  cells  is  quite  clear  in  the  FACS  log profiles  of fluorescence  intensity 
obtained  with  stained  populations.  The  variations  indicated  in  the  size  of  the 
populations  carrying  these  determinants  derive  from clear  and  reproducible  differ- 
ences between individuals. 
The identical  staining patterns  obtained with the Leu-2a and Leu-2b monoclonal 
antibodies suggest that the determinants  detected by these antibodies,  like the Lyt-2 
and  Lyt-3 determinants  (J.  A. Ledbetter and  L. A. Herzenberg, unpublished  obser- 
vations),  are  found on the  same  macromolecule and  appear  to be expressed  to the 
same extent  on the same cells  (Fig.  1).  Staining  with  a  mixture  of anti-Leu-2a and 
anti-Leu-2b  confirms  the  coincident  expression  of these  determinants  in  that  the 
frequency of ceils stained  with both  antibodies  is the same as the  frequency of cells 
stained with either antibody alone (data not shown). 
Biochemical  analyses  also show  that  the  anti-Leu-2a  and  anti-Leu-2b  antibodies 
immunoprecipitate  the  same  macromolecule  (Fig.  2)  which  is  quite  similar  to  the 
mouse Lyt-2, Lyt-3 macromolecule.  Both the human and the mouse macromolecules 
are  composed  of polypeptide  subunits  that  are  disulfide-bonded  into  a  variety  of 
multimeric  forms  (see Fig.  3).  The macromolecule immunoprecipitated  from mouse 
thymocytes has  subunits  of 30,000,  34,000,  and  38,000  molecular  weight  (relative) 
(Mr)  in SDS-polyacrylamide gels run under reducing conditions. The macromolecule 
from human thymocytes shows two subunits  (32,000 and 43,000 Mr).  The 32,000-Mr 
subunit  is quite broad, and there  is a  hint that  this band could be resolved into two 
separate bands.  Another possibility is that  the apparent  absence of the third subunit 
on  human  cells  could  be  a  result  of poor  125I-labeling,  because  one  of the  rpouse 
subunits  (30,000  Mr),  which  we  have  shown  carries  the  Lyt-3  determinant,  is  also 
often difficult to detect  under the labeling conditions used here (J.  A. Ledbetter and 
L. A.  Herzenberg.  Unpublished  observation.).  The subunits  of both  the  mouse and LEDBETTER  ET  AL.  313 
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FtG.  1.  FACS analysis of Leu-2a and Lyt-2 determinant expression on human and mouse lymphoid 
cells. The Leu-2a antigen on human thymocytes (Thy) (a) and peripheral blood lymphocytes (PBL) 
(c)  was  detected  by  indirect  staining  with  SKI  monoclonal  antibody  supernate  followed  by 
fluorescein-conjugated goat anti-mouse IgGl.  Lyt-2 antigen on mouse thymocytes (b) and lymph 
node ceils (d) was detected by direct staining with fluorescein-conjugated 53-6.7  antibody. Back- 
ground (second step alone or unstained cells)  is shown as the dotted line in each panel. Fluorescence 
distributions were analyzed with a FACS-II fitted with a logarithmic amplifier, 
human  molecules are exceptionally basic  among cell surface molecules  (isoelectric 
point >8) as judged by two-dimensional gel analyses (data not shown). 
Under nonreducing gel conditions, both the mouse Lyt-2, Lyt-3 and human Leu- 
2a,  Leu-2b  molecules from  thymocytes appear  in  several  larger  forms whose sizes 
suggest the association of subunits into dimers and tetramers (see Fig. 3). These forms 
from the thymus differ slightly in size from the molecules immunoprecipitated from 
peripheral lymphocytes (lymph node in mouse or peripheral blood in human)  (Fig. 
2). The subunits visible under reducing conditions show corresponding size differences. 
Thus, the quite similar patterns ofsubunit size and associations into muhimeric forms 
of the human and mouse macromolecules along with the FACS data presented above, 
suggests that these molecules are homologous. 
Trypsin digestion studies provide further indication of this homology because Leu- 
2a resembles Lyt-2 and Leu-2b resembles Lyt-3 in trypsin sensitivity. The Lyt-3 and 
Leu-2b  determinants  are  carried  on  a  relatively trypsin-sensitive segment  of each O
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TABLE  I 
Trypsin Sensitivity* of T Cell Antigens 
Cell type  Antibody  Mean fluorescence 
intensity$ 
Human PBL  Leu- 1  0.95 
Leu-2a  0.79 
Leu-2b  0.09 
Mouse spleen  Lyt- 1  0.98 
Lyt-2  0.76 
Lyt-3  <0.05 
* Trypsin treatment: 25 #g trypsin, 2 ×  107 cells for 10 min in 0.5-ml wells at 
370C. 
$ After trypsin treatment. Untreated controls =  1.0. 
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Fro.  4.  FACS analysis of Leu- 1 and Lyt-1 determinant expression on human and mouse lymphoid 
cells. The Leu-1 antigen on human thymocytes (Thy)  (a) and peripheral blood lymphocytes (PBL) 
(c)  was  detected  by  indirect  staining  with  SK5  monoclonal  antibody  supernate  followed  by 
fluorescein-conjugated goat anti-mouse IgG~. Lyt-I antigen on mouse thymocytes (b) and lymph 
node cells (LN')  (d) was detected by direct staining with fluorescein-conjugated 53-7.3  antibody. 
Background  (second step  alone  or  unstained  cells)  is  shown  as  the  dotted  line  in  each  panel. 
Fluorescence distributions were analyzed with a FACS-II fitted with a logarithmic amplifier. LEDBETTER  ET  AL. 
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Fro.  5.  FACS analysis of Leu-I  and Leu-2a determinant expression on human thymocytes. The 
scatter profile in (a) shows the gating for total live thymocytes and mid-size thymocytes (cortisone- 
resistant [C-R?])  used for the fluorescence profiles in  Co)  and (c).  The fluorescence profiles of the 
mid-size (C-R?) scatter gating is shown as a solid line. 
molecule which is removed almost completely from the peripheral lymphocyte surface 
by exposure to 50 #g/ml of trypsin for 10 min at 37°C (see Table I). Lye-2 and Leu- 
2a,  in  contrast,  are  poorly removed under  these conditions  (Table I)  and  require 
exposure to substantially more trypsin for complete removal. 
Lye-1 and Leu-I Show Similar Biochemical Characteristics and Determinant Density Distri- 
butions.  Fig.  3  shows  the  biochemical  similarities  between  the  Lyt-1  and  Leu-1 
glyeoproteins.  Both  consist  of single  polypeptide  chains  of ~67,000  Mr  (i.e.,  no 
disulfide-linked subunits)  that  show extensive charge heterogeneity on  two-dimen- 
sional gels (data not shown) as well as two or three lower molecular weight derivatives, 
depending on the lymphoid organ (Fig. 2) or T  cell line from which the molecules are 
derived. Recent internal labeling with [35S]methionine and pulse-chase studies show 
that the smaller molecular weight form of Leu- 1 is a precursor of the large form (data 
not shown). These results confirm the approximate size of the Leu-1 antigen that was 318  HOMOLOGOUS  MOUSE AND  HUMAN T  CELL  ANTIGENS 
previously reported  (19).  Both  Lyt-1  and Leu-1  are resistant to trypsin treatment of 
viable cells (Table I). 
Lyt-1  and  Leu-1  also show strikingly similar antigen density distributions (FACS 
fluorescence profiles) when human  and mouse thymocytes or peripheral lymphocytes 
are compared  (Fig. 4). The thymocyte profiles both show a  distinct shoulder of cells 
with  higher  antigen density.  This shoulder has been shown  in the  mouse to  derive 
from a  medullary (more mature)  subpopulation (7, 9) that contains cells in a  narrow 
size  range  slightly  larger  than  most  thymocytes  but  smaller  than  the  largest  cells 
located  in  the  subcapsular  region  (20).  FACS  profiles of human  cells that  fall  in a 
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with anti-Leu-I plus anti-Leu-2a (SKI) or anti-Lyt-I plus anti-Lyt-2 (53-6.7) (solid line). Human 
cells  were  stained  indirectly using monoclonal antibody supernates  followed  by  a  fluorescein- 
conjugated goat  anti-mouse IgG]  second-step  antibody. Mouse  cells were  stained with  directly 
fluorescein-conjugated  anti-Lyt-1 (53-7.3) and anti-Lyt-2 (53-6.7) antibodies. Fluorescence distri- 
butions were analyzed on a FACS-II fitted with a logarithmic amplifier. 
[  a  ~  Leu-2a 
,,  1  i Leu~3a  +  Leu-3a 
',!  ~-~ 
!  i  ~  :,, 
tl  12  i3  14  tl  i2  i3  =4 
FLUORESCENCE  INTENSITY  (lOgl0) 
FIG.  7.  Immunofluorescence  analysis of Leu-2 and Leu-3 peripheral T cell subpopulations. Human 
peripheral  blood [ymphocytes were stained indirectly with monoclonal antibody supernate followed 
by  fiuorescein-conjugated  goat  anti-mouse IgGl.  In  (a)  the  Leu-3a-  and  Leu-2a-  (detected  by 
monoclonal antibodies SK1 and SK3) positive cells were stained separately.  In (b) the cells were 
stained with anti-Leu-2a and anti-Leu-3a simuhaneously. Fluorescence distributions were analyzed 
using a FACS-II fitted with a logarithmic amplifier. LEDBETTER  ET  AL.  319 
similar size range to mouse medullary thymocytes show substantial enrichment of the 
bright Leu-1 thymocyte subpopulation  (Fig. 5);  therefore the cells under the bright 
shoulder in the profile of human thymocytes are probably medullary cells. 
In the Leu-1 FACS profile of human peripheral lymphocytes, as in the Lyt-1 profile 
of mouse peripheral T  cells, stained cells display the antigen  density of the bright 
(medullary) thymocyte subpopulation (Fig. 4). Thus both Lyt-1 in mouse and Leu-1 
in human appear to increase in density as thymocytes mature and to show correspond- 
ing densities on what seems to be the more mature population in thymus and the T 
cells that are found in the periphery. 
The  peripheral  T  cell  subpopulations  in  human  and  mouse  also  have  similar 
quantitative Leu-1 and Lyt-1 surface-density patterns. Less Lyt-1 is found on Lyt-2  ÷ 
cells than on Lyt-2- cells, as revealed by two-color FACS analyses (10). This difference 
is also revealed by additive staining profiles from cells stained with mixtures of Lyt-1 
and Lyt-2, which indicates that  the cells on the low antigen-density (duller) side of 
the Lyt-1 profile are selectively increased in staining brightness by inclusion of anti- 
Lyt-2 in the staining mixture (see Fig. 6). The Leu-I additive staining profile shows 
the same shift of the dull Leu-1 ÷ cells to the brighter side of the curve when anti-Leu- 
2a is added to the staining mixture. Thus again, the human and mouse antigens show 
strong  similarities  in  the  complex  pattern  of determinant  representation  on  cell 
subpopulations. 
Human THz-  (Helper/Inducer)  T Cells Carry Antzgens (Leu-3a and Leu-3b)  Not Found on 
THe  ÷ (Cytotoxic/Suppressor)  T  Cells.  Our recent studies  (Introduction) have shown 
that Lyt-1 determinants are found on all T  cells, although in smaller amounts on the 
Lyt-2  + cells than on Lyt-2- cells. As shown above, the Leu-1 marker on human cells 
closely parallels the Lyt-1 marker distribution. Interestingly, unlike the mouse Lyt-1  +, 
Lyt-2- population, the human Leu-1 +, Leu-2- population has a distinctive molecular 
species, Leu-3 (55,000 Mr; Fig. 3) with two determinants, Leu-3a and Leu-3b, detected 
by two other monoclonal antibodies, SK3 and SK4.  z The Leu-3 antigen seems to be 
distributed similarly to the T4 antigen reported by Reinherz et al.  (13,  14). 
As reported earlier using cytofluorograph analysis,  2 FACS profiles (Fig. 7) demon- 
strate that  the Leu-2 and  Leu-3 antigens are on nonoverlapping subpopulations of 
peripheral blood T  cells. The fluorescence distribution obtained with a mixture of the 
two  antibodies  is  the  composite  of the  distributions  obtained  with  each  of the 
antibodies alone. The Leu-2 and Leu-3 cells represent >90% of the number of cells 
stained with anti-Leu-1 or another pan-T cell monoclonal antibody, SK7 (Fig. 2). 
Discussion 
Homologies or analogies between human  and  mouse T  cell antigens  have been 
proposed (15, 21) but the homologues were not based on direct comparisons nor did 
they take account of all the data now available. The assignment of the T4 antigen as 
the Lyt-1 homologue (15, 21) is not correct, in our opinion, as T4 is a unique marker 
of helper/inducer antigens whereas Lyt- 1 is on all T  cells.  Leu- 1 is our candidate for 
the  Lyt-1 homologue, and  no mouse equivalent  of T4 is known.  Our evidence on 
homologies derives from comparing the mouse and human antigens by determination 
of their density distributions on thymocytes and T  cells by FACS analysis; their size, 
charge, and subunit compositions; and by their sensitivities to proteolysis by trypsin. 320  HOMOLOGOUS MOUSE AND HUMAN T  CELL ANTIGENS 
We feel this evidence strongly supports the idea that the Leu-1  and Leu-2a, Leu-2b 
molecules are the human homologues of the mouse Lyt-1 and Lyt-2, Lyt-3 molecules. 
The  Leu-1  antigen  is  unique  among  human  T  lymphocyte  antigens  thus  far 
detected  by monoclonal  antibodies  because  it  is  found on  Ig  + leukemic cells  from 
most patients with chronic lymphocytic leukemia (CLL) but is not found on normal 
B cells. Although  the presence of Leu-1  on a  small subpopulation of normal B cells 
cannot be excluded, it was previously proposed that this antigen is induced on CLL 
cells  as  a  consequence  of leukemogenesis  (19).  This observation,  together with  the 
previously  reported  molecular  weight  of Leu-1  (69,000-71,000  dalton),  raised  the 
possibility  that  this  antigen  is  related  to  the  mouse endogenous  viral  gp70-related 
antigen GIX, which is also expressed on leukemias derived from GIX- cells (22). 
The Leu-1/Lyt-1 analogy now demonstrated is not consistent with the above view 
because the size and charge properties of Lyt-1 on two-dimensional gel analyses are 
distinct  from those of gp70.  Furthermore, Lyt-1 carries no detectable gp70 determi- 
nants because it does not react with a  broadly reactive (group-specific) heterologous 
anti-gp70  antiserum  (J.  A.  Ledbetter and  L. A.  Herzenberg, unpublished  observa- 
tions). Lyt-1 is similar to Leu-1 in its expression on B cell leukemias, as Lyt-1 also has 
now been found in high levels on 3 of 15 surface-Ig  + B cell leukemias (L. Lanier, N. 
Warner, J. A. Ledbetter, and L. A. Herzenberg, unpublished observation). Although 
Lyt-1 has not been detected on normal B cells in suspension, it is found on a few Thy- 
1- cells in B cell areas of frozen sections of lymph node and spleen (10). 
The apparent conservation of the molecular structure and subpopulation density 
distributions  for the Leu and Lyt antigens suggests that  these surface structures are 
not  simply convenient  markers that  allow  the  distinction  of T  cell  populations  at 
various  stages  of  maturity  or  with  different  functional  capabilities.  Rather,  the 
maintenance  of these  structures  throughout  evolution  seems  more  likely  to  have 
occurred because these molecules perform essential functions  for the cells on which 
they are found.  Such  functions  are probably reflected in  the absolute changes that 
occur during differentiation  (e.g., Lyt-2+/Leu-2a  ÷ to Lyt-2-/Leu-2a-), the quantita- 
tive  changes  that  occur  (e.g.,  Lyt-1/Leu-I  dull  to  Lyt-1/Leu-1  bright),  and  the 
maintenance of selective quantitative expression patterns in different subpopulations 
(e.g., less Lyt-l/Leu-1 on Lyt-2+/Leu-2a  + cells than on Lyt-2-/Leu-2a- cells); which, 
if any,  of  these  changes  are  directly  related  to  effector  functions  and  which  are 
involved in the ability to send or receive differentiation signals is not clear. 
As we have indicated, the forms of the Lyt-2, Lyt-3/Leu-2a, Leu-2b macromolecule 
present on thymocytes differ from those found on peripheral T  cells. Whether these 
differences are a  result of modifications in primary structure or of the carbohydrate 
moiety of the molecule, and whether they relate to the molecule's functional properties 
is still unknown.  Further biochemical studies on these molecules may help elucidate 
how they work. 
As with Lyt-2, Lyt-3 in the mouse, Leu-2a, Leu-2b is found on virtually all cortical 
(immature)  thymocytes  but  is  selectively  expressed  on  the  suppressor  subset  of 
peripheral T  cells.  The mean determinant density of these antigens in both species is 
higher on the peripheral T  cells than in the thymus. A clue to the function of the Lyt- 
2,  Lyt-3  molecule  is  that  cytotoxic  T  lymphocyte  (CTL)  killing  of target  cells  is 
specifically blocked by anti-Lyt-2 or anti-Lyt-3 but  not by antibodies to other CTL 
surface antigens  (23,  24).  The specific blocking of CTL killing is also seen with anti- LEDBETTER  ET  AL.  321 
Leu-2a  and  anti-Leu-2b  in  man. 2 These  findings,  properly,  have  been  cautiously 
interpreted, as the blocking could be a result of a tendency for the Lyt-2, Lyt-3/Leu- 
2a, Leu-2b molecule to associate with other molecules relevant to the killing activity. 
This cautious interpretation is supported by recent data (J. A. Ledbetter, W. Seaman, 
T. Tsu, and  L. A.  Herzenberg, unpublished  observations)  which  show  that  trypsin 
treatment selectively removes most of the Lyt-3 subunit and causes nonparallel losses 
of cytolytic activity. If the Lyt-3 subunit  were directly involved in T  cell killing, we 
should have found parallel losses of the antigen and cytolytic activity. 
The loci controlling  Lyt-2 and  Lyt-3 are closely linked  to each other and  to the 
mouse ~¢-chain region on chromosome 6 (25-28). This close linkage may, of course, be 
fortuitous. If, however, the homologous human genes Leu-2a, Leu-2b, and K are also 
found to be closely linked, then linkage may be evolutionarily maintained to permit 
functional  interaction  between  these  genes.  An  obvious possibility is  that  VK gene 
products are associated with the Lyt-2, Lyt-3 molecule. However, control of expression 
of these linked genes seems to be different, as Lyt-2, Lyt-3 are not allelically excluded 
(.J.A.  Ledbetter  and  L.  A.  Herzenberg,  unpublished  observations), whereas  VK  is 
allelically excluded on B cells and may also be allelically excluded on T  cells. 
The definition of the human helper/inducer subset by a specific antigen, Leu-3 or 
T4 (21), has no known murine counterpart, Such an antigen, if it exists, is presumably 
not  polymorphic because it has not  been  found  by the extensive alloimmunization 
studies performed in the mouse. However, new hybridomas obtained using xenogeneic 
immunization  may yield  a  monoclonal  antibody  revealing  this  antigen  on  mouse 
helper T  cells. 
Summary 
We  describe  the  biochemical  properties  and  cell  surface  distributions  of three 
human  T  cell  antigens  (Leu-1,  Leu-2a,  and  Leu-2b)  which  we postulate  to  be the 
homologues of the Lyt-1, Lyt-2, and Lyt-3 antigens that distinguish functional T  cell 
subsets in  the mouse.  Leu-l, like Lyt-1, is on all thymocytes and  peripheral T  cells 
and is present in greater amounts on the helper/inducer subset than on the cytotoxic/ 
suppressor subset. Both antigens increase in parallel fashion during T  cell maturation 
in  the  thymus  and  each  antigen  is  carried  on  a  single  67,000-molecular  weight 
(relative)  (Mr)  polypeptide chain.  Surprisingly,  Leu-1  and  Lyt-1  each  are  also  ex- 
pressed in readily detectable amounts on some B celI Ieukemias but not detectably so 
on normal B cells. 
Leu-2a  and  Leu-2b  are antigens  found  only on  suppressor/cytotoxic cells  in  the 
human and are very similar to the murine Lyt-2 and Lyt-3 antigens. In both species, 
the two antigens are on the same disulfide-  linked  multimeric molecules.  Disulfide- 
bond reduction  in both species yields subunits of similar size and charge.  Lyt-3 and 
Leu-2b are extremely sensitive to trypsin digestion on viable cells whereas Lyt-2 and 
Leu-2a are much less so. 
A different membrane antigen, Leu-3, is an exclusive marker of the helper/inducer 
subset in man. No mouse homologue for this 55,000-Mr protein is known. 
The  maintenance  of the  homologous  molecules  on  functionally  distinct  T  cell 
subpopulations  in  two evolutionarily  distant  species suggests that  the  Lyt and  Leu 
antigens perform essential functions for the cells on which they are found. 322  HOMOLOGOUS  MOUSE AND HUMAN T  CELL ANTIGENS 
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